 |
2006-11-20 News Release
Biomedical Materials
JV with electro active polymers biz
Corporate venturing unit invests in advanced materials company involved
in the development of electro active polymers for medical applications.
DSM Venturing, the corporate venturing unit of Royal DSM N.V., today
announced that it has taken a share of 10% in the advanced materials company
Micromuscle. Micromuscle has developed electro-active polymers (EAPs)
for use in medical devices and life science product applications. This
investment will give DSM a perfect window on the potential of EAP technology
for medical applications.
Find Information and Suppliers of polymeric
systems.
Micromuscle’s electro-active polymer technology is based on the
discovery of conducting polymers, i.e. plastics capable of conducting
electricity. Micromuscle holds a strong IPR portfolio including patents
and patent applications. Micromuscle focuses on vascular applications
where EAP has considerable potential and enables new functionality for
medical devices.
Electro active polymers are an emerging class of advanced materials with
new revolutionary properties. A primary advantage of EAPs is the possibility
to electrically control their behavior and properties. This enables the
construction of small, moving and force-exerting components called actuators
or micromuscles. The EAP technology can be used in medical devices and
enables new applications by performing a range of functions, such as control
of the movement and properties of medical devices, the anchoring of devices,
and controlled drug release. Currently, Micromuscle is focusing on vascular
applications.
|
EAP technology - steerable
vascular device maneuvering in vessels. Click
Go for larger image. photo: Micromuscle |
|
DSM and Micromuscle
will explore opportunities for joint development products, especially
in the area of drug delivery and cardiovascular systems. These are fields
DSM is currently focusing on in its Emerging Business Area of Biomedical
Materials (DSM Biomedical), which is one of the focus areas to secure
longer-term growth as defined in DSM's corporate strategy program Vision
2010 - Building on Strengths, which focuses on accelerating profitable
and innovative growth of the company's specialties portfolio.
In close cooperation with external parties, DSM
Biomedical
is active in extensive R&D that is expected to generate the innovations
of the future, such as polymer implants, medical coatings, and polymeric
systems for the controlled release of medicines in the body. DSM Biomedical
draws upon DSM's expertise in the fields of polymers, coatings and material
sciences combined with its strong position in life sciences. Steve Hartig,
Vice President DSM Biomedical: 'We look forward to working together with
Micromuscle. They have succeeded in carving out an interesting position
in electro active polymers for biomedical materials. Their expertise in
combination with our broad competences in polymers and growing expertise
in medical therapies should lead to valuable new applications. This cooperation
illustrates once more how we put open innovation into practice at DSM.'
Find information about DSM.
Read a recent press release from DSM about - The new factory for waterborne
coating resins will be built at an existing DSM production site in
Meppen, Germany, which produces specialty products.
Polymer
Engineering Jobs - Post Employment Opportunity!
Click
here to view more news headlines.
E-mail this page to a friend 
|
|
News / Resources
- Enzymes potential
application in producing polymers
- Certification, Training and Courses
from The American Management Association
- Small
Quantity Specailist - Plastics, Metals, Tool Steel and ...
-
Looking for a Study Program?
- All this Months News
- Changing Jobs? View
Homes for Sale Nationwide
- Golf Equipment Manufacturer
-Buy direct and Save!
- Maybe
it's time to check your Home Owners Insurance
Copyright
- Unless otherwise
stated all contents of this web site are © 1998/2006 JOBWERX.COM.
– All Rights Reserved. For permission to reproduce any contents of this
web site, please advise our Syndication department: Log onto HELP
|
